It is now apparent that the action of interferon (IF) on cells is not solely manifested as resistance of the cells to viral challenge. The scope of IF activity has expanded to include protection against the intracellular protozoa (8), Rickett .sia (4) , and Chlamydia (6) , and also the ability to prime cells for enhanced IF production (9) , to depress the growth rate of normal and tumor cells (6) , and to enhance phagocytosis of carbon particles by mouse macrophages (3) .
Concerning the latter property, we concluded (3) that IF and the phagocytosis-enhancing factor in IF preparations were identical because they are indistinguishable physicochemically and biologically. This The previously described procedures for phagocytosis assay were followed except in the macrophage harvesting process. A medium was designated as the conditioned medium, which was made of nine parts of Eagle minimum essential medium (EMEM) and one part of filtered (0.45-pm pore-size membrane) culture medium of Lcell line of mouse fibroblasts (L cells) supplemented with 15% horse serum and antibiotics. Mouse peritoneal macrophages were harvested with the conditioned medium as described previously. After the low-speed centrifugation, cells were washed immediately. Cultures initiated in this way were incubated at 37 C for 2.5 h in the conditioned medium, after which they were washed again and supplied with the regular medium (3) supplemented with 15% horse serum until they were to be used in an assay. At that time the test samples, and later carbon particles, were diluted in the regular medium supplemented with 7% horse serum and were applied to the cells as previously described (3) . Repeated tests have shown that these procedural changes provide more consistently satisfactory macrophage cultures that are unaltered in their response to the enhancing effect of IF preparations.
The IF preparations that were tested in the first series of experiments are listed in Table 1 . Serum IF induced by Newcastle disease virus (NDV) was prepared as previously described (preparation 10; reference 3). Immediately after the serum IF was harvested, some mice were injected intraperitoneally (i.p.) with 2.5 ml of EMEM supplemented with 15% fetal bovine serum and antibiotics. The peritoneal fluids were immediately collected and saved as one of the IF preparations (preparation 3). A second serum IF was prepared by exsanguinating mice 21 h after i.p. injection of 4 mg of Statolon, obtained from W. J. Kleinschmidt (preparation 2). Confluent L cells and MSV-Ia cells (1), obtained from S. Baron through G. Spahn, were used for in vitro production of IF. The L cells were inoculated with ultraviolet-irradiated NDV and incubated for 75 min before the cells were washed. Culture medium that consisted of EMEM with 2% fetal bovine serum and antibiotics was added to the cells and harvested 24 h later as another IF preparation (preparation 4). The MSV-Ia cells were handled similarly, except that nonirradiated NDV was used, the cells were not washed after the removal of the inoculum, and the medium containing IF was harvested after an 18-h incubation period (preparation 5). Controls for all these preparations consisted of serum and peritoneal exudates or medium from animals or cell cultures which had undergone mock induction.
These IF and control preparations were subjected to various physicochemical treatments (Table 1 ) and assayed for antiviral activity in L cells with vesicular stomatitis virus as the challenging virus (3). Then, in repeated experiments, samples of each preparation were diluted and incubated with the macrophage cultures. As shown in Table 1 , the enhancing effect is consistently seen with IF preparations regardless of source, means of induction, and physicochemical treatments.
A second series of experiments was designed to see if anti-IF serum would inhibit the enhancement of phagocytosis by IF preparations. A highly specific lyophilized anti-L-cell IF globulin was obtained from K. Pauker. In our hands, a 1:400 and a 1:800 dilution of this globulin neutralized 100% and 66%, respectively, of the antiviral activity of 50 U of mouse serum IF (equivalent to 50 National Institutes of Health international reference units), whereas a 1:1,600 dilution had no apparent effect.
When several different IF preparations were mixed and incubated with dilutions of this globulin for 45 min at 37 C and then assayed for phagocytosis-enhancing activity, their capacity to enhance phagocytosis was blocked by the globulin at concentrations similar to those which effectively neutralized antiviral activity. Representative results of these experiments are presented in Table 2 .
In experiment 1 the activity of the IF preparation 4B was considerably reduced by a 1:1,600 dilution of this globulin. This was attributed to the relative instability of this particular batch of L-cell IF. In fact, the magnitude of neutralization of the enhancing effect of the two IF preparations by the 1:400 dilution of the globulin in experiment 1 was also greater than expected. The possibility thus remained that the globulin had a depressive effect on the phagocytic activity of macrophages that disappeared when the globulin was diluted beyond a certain point. This possibility can be discounted on the basis of the results in experiment 2, where no depressive effect was seen with cells treated with 1:200 dilution of globulin alone. Moreover, the results from an additional experiment showed that the activity t)'O2 (3) . Much speculation could be made about how this phenomenon, if operative in vivo, may affect the role of the macrophage in the overall defense mechanisms of the host. Our findings could provide at least a partial explanation for the protective effect of IF in animals against bacterial and protozoal infections. In this respect, it should be noted that in those studies where IF inducers were shown to stimulate reticuloendothelial clearance of bacteria (7) and protozoa (2), the authors concluded that the involvement of IF was inconsequential. Obviously, further study inl this area is required.
